Vical Incorporated (VICL) news: Vical's CEO Discusses Q4 2013 Results ... Seeking Alpha Our partner Astellas is making steady progress enrolling patients in this phase III trial of TransVax in stem cell transplant recipients and its phase II trial of transplants and solid organ transplant recipients. We will report future progress as it ... Vical Reports 2013 Financial Results and Progress in Key Development Programs |
